Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03265197Phase 1Completed
Phase 1, randomised, double-blind trial of lidocaine in tinnitus (2 arms). Primary endpoints: Self-reported significant improvement in tinnitus at 6 months and Medication complication and side effect at 6 months. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03265197.